Highly Satisfactory Accuracy for the UltraGene Combo2Screen SARS-CoV-2 Assay on the QCMD 2020 SARS-CoV-2 EQA Programme

We are pleased to announce that the UltraGene Combo2Screen SARS-CoV-2 Assay has obtained Highly Satisfactory results (with a 100% accuracy for qualitative detection of all QCMD blinded samples, including with lowest viral load) in the context of the QCMD 2020 SARS-CoV-2 EQA Programme (SCV2_20 – QAV204215_1).

The QCMD is an independent International External Quality Assessment (EQA) / Proficiency Testing (PT) organisation, providing wide-ranging quality assessment services. This organisation primarily focuses on molecular infectious diseases.